The Korean Organ Transplantation Registry (KOTRY): an overview and summary of the kidney-transplant cohort

被引:11
作者
Jeon, Hee Jung [1 ]
Koo, Tai Yeon [2 ]
Ju, Man Ki [3 ]
Chae, Dong-Wan [4 ]
Choi, Soo Jin Na [5 ]
Kim, Myoung Soo [6 ]
Ryu, Jung-Hwa [7 ]
Jeon, Jong Cheol [4 ]
Ahn, Curie [8 ]
Yang, Jaeseok [9 ]
机构
[1] Hallym Univ, Kangdong Sacred Heart Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Seongnam Citizens Med Ctr, Dept Internal Med, Seongnam, South Korea
[3] Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea
[4] Seoul Natl Univ, Dept Internal Med, Div Nephrol, Bundang Hosp, Seongnam, South Korea
[5] Chonnam Natl Univ, Dept Surg, Med Sch, Gwangju, South Korea
[6] Yonsei Univ, Severance Hosp, Dept Transplant Surg, Coll Med, Seoul, South Korea
[7] Ewha Womans Univ, Dept Internal Med, Med Ctr, Seoul, South Korea
[8] Natl Med Ctr, Dept Internal Med, Seoul, South Korea
[9] Yonsei Univ, Severance Hosp, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
关键词
Cohort studies; Kidney transplantation; Registries; Republic of Korea; ACUTE REJECTION; MYCOPHENOLATE-MOFETIL; RECENT PROGRESSES; PATIENT SURVIVAL; RISK-FACTORS; RECIPIENTS; INFECTION; BORTEZOMIB; MORTALITY; DIALYSIS;
D O I
10.23876/j.krcp.21.185
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: As the need for a nationwide organ-transplant registry emerged, a prospective registry, the Korean Organ Transplanta-tion Registry (KOTRY), was initiated in 2014. Here, we present baseline characteristics and outcomes of the kidney-transplant cohort for 2014 through 2019. Methods: The KOTRY consists of five organ-transplant cohorts (kidney, liver, lung, heart, and pancreas). Data and samples were pro-spectively collected from transplant recipients and donors at baseline and follow-up visits; and epidemiological trends, allograft out-comes, and patient outcomes, such as posttransplant complications, comorbidities, and mortality, were analyzed. Results: From 2014 to 2019, there were a total of 6,129 registered kidney transplants (64.8% with living donors and 35.2% with de-ceased donors) with a mean recipient age of 49.4 +/- 11.5 years, and 59.7% were male. ABO-incompatible transplants totaled 17.4% of all transplants, and 15.0% of transplants were preemptive. The overall 1-and 5-year patient survival rates were 98.4% and 95.8%, respectively, and the 1-and 5-year graft survival rates were 97.1% and 90.5%, respectively. During a mean follow-up of 3.8 years, bi-opsy-proven acute rejection episodes occurred in 17.0% of cases. The mean age of donors was 47.3 +/- 12.9 years, and 52.6% were male. Among living donors, the largest category of donors was spouses, while, among deceased donors, 31.2% were expanded -crite-ria donors. The mean serum creatinine concentrations of living donors were 0.78 +/- 0.62 mg/dL and 1.09 +/- 0.24 mg/dL at baseline and 1 year after kidney transplantation, respectively. Conclusion: The KOTRY, a systematic Korean transplant cohort, can serve as a valuable epidemiological database of Korean kidney transplants.
引用
收藏
页码:492 / 507
页数:16
相关论文
共 40 条
[1]   Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry [J].
Abeling, Tanja ;
Scheffner, Irina ;
Karch, Annika ;
Broecker, Verena ;
Koch, Armin ;
Haller, Hermann ;
Schwarz, Anke ;
Gwinner, Wilfried .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (07) :1171-1181
[2]   Initial Report of the Korean Organ Transplant Registry: The First Report of National Kidney Transplantation Data [J].
Ahn, C. ;
Koo, T. Y. ;
Jeong, J. C. ;
Kim, M. ;
Yang, J. ;
Lee, J. ;
Min, S. I. ;
Lee, J. E. ;
Kim, M. S. ;
Kwon, O. J. ;
Kim, S. J. ;
Kim, Y. H. ;
Kim, Y. H. ;
Choi, B. S. ;
Choi, S. J. N. ;
Lee, D. -H. ;
Chung, S. Y. ;
Cho, W. H. ;
Kim, Y. S. .
TRANSPLANTATION PROCEEDINGS, 2014, 46 (02) :425-430
[3]   Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk? [J].
Bhat, Mamatha ;
Watt, Kymberly D. .
CLINICAL TRANSPLANTATION, 2015, 29 (07) :654-663
[4]   Risk Stratification for Rejection and Infection after Kidney Transplantation [J].
Cippa, Pietro E. ;
Schiesser, Marc ;
Ekberg, Henrik ;
van Gelder, Teun ;
Mueller, Nicolas J. ;
Cao, Claude A. ;
Fehr, Thomas ;
Bernasconi, Corrado .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (12) :2213-2220
[5]  
Cusumano Ana Maria, 2016, World J Nephrol, V5, P389, DOI 10.5527/wjn.v5.i5.389
[6]   Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients - An analysis of USRDS data [J].
Dharnidharka, V. R. ;
Agodoa, L. Y. ;
Abbott, K. C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (03) :653-661
[7]   A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection [J].
Eskandary, Farsad ;
Regele, Heinz ;
Baumann, Lukas ;
Bond, Gregor ;
Kozakowski, Nicolas ;
Wahrmann, Markus ;
Hidalgo, Luis G. ;
Haslacher, Helmuth ;
Kaltenecker, Christopher C. ;
Aretin, Marie-Bernadette ;
Oberbauer, Rainer ;
Posch, Martin ;
Staudenherz, Anton ;
Handisurya, Ammon ;
Reeve, Jeff ;
Halloran, Philip F. ;
Boehmig, Georg A. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (02) :591-605
[8]   32 Doses of Bortezomib for Desensitization Is Not Well Tolerated and Is Associated With Only Modest Reductions in Anti-HLA Antibody [J].
Gonzales, Manuel A. Moreno ;
Gandhi, Manish J. ;
Schinstock, Carrie A. ;
Moore, Natalie A. ;
Smith, Byron H. ;
Braaten, Nong Y. ;
Stegall, Mark D. .
TRANSPLANTATION, 2017, 101 (06) :1222-1227
[9]   Mycophenolate Mofetil and Tacrolimus Reduce Mortality After Deceased Donor Kidney Transplantation [J].
Gonzalez-Molina, M. ;
Ruiz-Esteban, P. ;
Burgos, D. ;
Rodriguez, M. A. ;
Cabello, M. ;
Gutierrez, E. ;
Hernandez, D. .
TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) :2577-2578
[10]   Infectious Complications After Deceased Kidney Donor Transplantation [J].
Guimaraes-Souza, N. K. ;
Dalboni, M. A. ;
Camara, N. C. ;
Medina-Pestana, J. O. ;
Paheco-Silva, A. ;
Cendoroglo, M. .
TRANSPLANTATION PROCEEDINGS, 2010, 42 (04) :1137-1141